Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 24, No 20 (July 10), 2006: pp. 3225-3233
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.06.5656

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schnall, M.
Right arrow Articles by Rosen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schnall, M.
Right arrow Articles by Rosen, M.

REVIEW ARTICLE

Primer on Imaging Technologies for Cancer

Mitchell Schnall, Mark Rosen

From the Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA

Address reprint requests to Mitchell Schnall, MD, Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104; e-mail: mitchell.schnall{at}uphs.upenn.edu

Medical images represent maps of the spatial distribution of tissue properties. Each modality probes a specific set of tissue properties such as x-ray attenuation for computed tomography, transmission of sound for ultrasound, and the rate of glucose uptake for fluorodeoxyglucose–positron emission tomography. Understanding the basic principal underlying each modality is important for developing approaches to utilize imaging in cancer research and clinical care. In addition, each modality has specific challenges related to reliable quantitation that are important to appreciate.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
R. M. Sharkey, H. Karacay, W. J. McBride, E. A. Rossi, C.-H. Chang, and D. M. Goldenberg
Bispecific Antibody Pretargeting of Radionuclides for Immuno Single-Photon Emission Computed Tomography and Immuno Positron Emission Tomography Molecular Imaging: An Update
Clin. Cancer Res., September 15, 2007; 13(18): 5577s - 5585s.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
D. A. Torigian, S. S. Huang, M. Houseni, and A. Alavi
Functional Imaging of Cancer with Emphasis on Molecular Techniques
CA Cancer J Clin, July 1, 2007; 57(4): 206 - 224.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. L. Ehman, W. R. Hendee, M. J. Welch, N. R. Dunnick, L. B. Bresolin, R. L. Arenson, S. Baum, H. Hricak, and J. H. Thrall
Blueprint for Imaging in Biomedical Research
Radiology, July 1, 2007; 244(1): 12 - 27.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online